JP2003521229A5 - - Google Patents

Download PDF

Info

Publication number
JP2003521229A5
JP2003521229A5 JP2000588351A JP2000588351A JP2003521229A5 JP 2003521229 A5 JP2003521229 A5 JP 2003521229A5 JP 2000588351 A JP2000588351 A JP 2000588351A JP 2000588351 A JP2000588351 A JP 2000588351A JP 2003521229 A5 JP2003521229 A5 JP 2003521229A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000588351A
Other languages
Japanese (ja)
Other versions
JP2003521229A (ja
Filing date
Publication date
Priority claimed from PCT/US1999/012252 external-priority patent/WO1999063088A2/en
Application filed filed Critical
Priority claimed from PCT/US1999/028634 external-priority patent/WO2000036102A2/en
Publication of JP2003521229A publication Critical patent/JP2003521229A/ja
Publication of JP2003521229A5 publication Critical patent/JP2003521229A5/ja
Withdrawn legal-status Critical Current

Links

JP2000588351A 1998-12-16 1999-12-01 分泌及び膜貫通ポリペプチドとそれをコードする核酸 Withdrawn JP2003521229A (ja)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US11314598P 1998-12-16 1998-12-16
US11285198P 1998-12-16 1998-12-16
US60/113,145 1998-12-16
US60/112,851 1998-12-16
US11351198P 1998-12-22 1998-12-22
US60/113,511 1998-12-22
US11555899P 1999-01-12 1999-01-12
US11556599P 1999-01-12 1999-01-12
US11573399P 1999-01-12 1999-01-12
US60/115,558 1999-01-12
US60/115,733 1999-01-12
US60/115,565 1999-01-12
US11934199P 1999-02-09 1999-02-09
US60/119,341 1999-02-09
US11953799P 1999-02-10 1999-02-10
US60/119,537 1999-02-10
US11996599P 1999-02-12 1999-02-12
US60/119,965 1999-02-12
US99/12252 1999-06-02
PCT/US1999/012252 WO1999063088A2 (en) 1998-06-02 1999-06-02 Membrane-bound proteins and nucleic acids encoding the same
PCT/US1999/028634 WO2000036102A2 (en) 1998-12-16 1999-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP2003293651A Division JP2004041218A (ja) 1998-12-16 2003-08-14 分泌ポリペプチドとそれをコードする核酸
JP2003293650A Division JP2004041217A (ja) 1998-12-16 2003-08-14 分泌及び膜貫通ポリペプチドとそれをコードする核酸
JP2006282251A Division JP2007075118A (ja) 1998-12-16 2006-10-17 分泌及び膜貫通ポリペプチドとそれをコードする核酸

Publications (2)

Publication Number Publication Date
JP2003521229A JP2003521229A (ja) 2003-07-15
JP2003521229A5 true JP2003521229A5 (enExample) 2005-12-22

Family

ID=27578476

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2000588351A Withdrawn JP2003521229A (ja) 1998-12-16 1999-12-01 分泌及び膜貫通ポリペプチドとそれをコードする核酸
JP2003293651A Withdrawn JP2004041218A (ja) 1998-12-16 2003-08-14 分泌ポリペプチドとそれをコードする核酸
JP2003293650A Withdrawn JP2004041217A (ja) 1998-12-16 2003-08-14 分泌及び膜貫通ポリペプチドとそれをコードする核酸
JP2006282251A Withdrawn JP2007075118A (ja) 1998-12-16 2006-10-17 分泌及び膜貫通ポリペプチドとそれをコードする核酸
JP2007156006A Withdrawn JP2007312779A (ja) 1998-12-16 2007-06-13 分泌及び膜貫通ポリペプチドとそれをコードする核酸

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2003293651A Withdrawn JP2004041218A (ja) 1998-12-16 2003-08-14 分泌ポリペプチドとそれをコードする核酸
JP2003293650A Withdrawn JP2004041217A (ja) 1998-12-16 2003-08-14 分泌及び膜貫通ポリペプチドとそれをコードする核酸
JP2006282251A Withdrawn JP2007075118A (ja) 1998-12-16 2006-10-17 分泌及び膜貫通ポリペプチドとそれをコードする核酸
JP2007156006A Withdrawn JP2007312779A (ja) 1998-12-16 2007-06-13 分泌及び膜貫通ポリペプチドとそれをコードする核酸

Country Status (8)

Country Link
EP (1) EP1141285A2 (enExample)
JP (5) JP2003521229A (enExample)
KR (2) KR100468978B1 (enExample)
AU (7) AU777006B2 (enExample)
CA (1) CA2348757A1 (enExample)
IL (11) IL142794A0 (enExample)
MX (1) MXPA01006057A (enExample)
WO (1) WO2000036102A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7192589B2 (en) 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US7419663B2 (en) 1998-03-20 2008-09-02 Genentech, Inc. Treatment of complement-associated disorders
US6914130B2 (en) * 1998-06-17 2005-07-05 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
AU2008201101B2 (en) * 1999-03-11 2011-01-20 Merck Serono Sa Vascular adhesion molecules and modulation of their function
CN1637019A (zh) 1999-03-11 2005-07-13 Rmf迪克塔吉恩有限公司 血管粘着分子及其功能的调节
KR100543857B1 (ko) * 1999-09-01 2006-01-23 제넨테크, 인크. 혈관신생 및 심혈관형성의 촉진 또는 억제
DE19947010A1 (de) * 1999-09-30 2001-04-05 Universitaetsklinikum Freiburg Das Gen PRV-1 und dessen Verwendung
AU2001259191A1 (en) * 2000-04-28 2001-11-12 Millennium Pharmaceuticals, Inc. 25692, a novel human o-methyltransferase family member and uses thereof
GB0110273D0 (en) * 2001-04-26 2001-06-20 Inpharmatica Ltd Novel proteins
WO2003053334A2 (en) * 2001-12-19 2003-07-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2003097862A1 (en) * 2002-05-17 2003-11-27 Kyowa Hakko Kogyo Co., Ltd. Method of searching substane having antidiabetic activity
WO2004031392A1 (en) * 2002-10-02 2004-04-15 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis
ES2551202T5 (es) 2005-11-04 2018-11-30 Genentech, Inc. Uso de inhibidores de la vía del complemento para tratar enfermedades oculares
AU2007301599B2 (en) 2006-09-28 2013-01-10 Merck Serono S.A. Junctional Adhesion Molecule-C (JAM-C) binding compounds and methods of their use
CN106084054A (zh) 2006-11-02 2016-11-09 健泰科生物技术公司 人源化的抗‑d因子抗体
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
LT2280996T (lt) 2008-05-06 2016-12-12 Genentech, Inc. Subrendusio giminingumo crig variantai
CR20160132A (es) 2013-08-12 2016-08-25 Genentech Inc Composiciones y método para tratar condiciones asociadas con el complemento
SG11201608868PA (en) 2014-05-01 2016-11-29 Genentech Inc Anti-factor d antibody variants and uses thereof
EP3368090A1 (en) 2015-10-30 2018-09-05 H. Hoffnabb-La Roche Ag Anti-factor d antibody variant conjugates and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001970A (en) * 1994-11-07 1999-12-14 Merck & Co., Inc Modified human neuropeptide Y1 Receptors
WO1997025427A1 (en) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mcp-2)
AU746956B2 (en) * 1997-05-06 2002-05-09 Zymogenetics Inc. Novel tumor antigens
DE19818620A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Normal
EP1090118A2 (en) * 1998-06-26 2001-04-11 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
WO2000004135A2 (en) * 1998-07-16 2000-01-27 Incyte Pharmaceuticals, Inc. Human scad-related molecules, scrm-1 and scrm-2
DE19849044A1 (de) * 1998-10-23 2000-04-27 Univ Ludwigs Albert Das Gen PRV-1 und dessen Verwendung
JP2002530080A (ja) * 1998-11-19 2002-09-17 インサイト・ファーマスーティカルズ・インコーポレイテッド 免疫グロブリン・スーパーファミリー・タンパク質
DK1607402T3 (da) * 1999-03-08 2007-04-16 Genentech Inc Sammensætninger og fremgangsmåder til tumorbehandling

Similar Documents

Publication Publication Date Title
BE2018C020I2 (enExample)
BE2015C057I2 (enExample)
BE2016C007I2 (enExample)
BE2015C018I2 (enExample)
BE2014C017I2 (enExample)
BE2013C051I2 (enExample)
BE2013C020I2 (enExample)
BE2013C015I2 (enExample)
BE2013C001I2 (enExample)
BE2012C036I2 (enExample)
BE1025464I2 (enExample)
BE2008C046I2 (enExample)
BE2010C011I2 (enExample)
BRPI0017527B8 (enExample)
BE2008C047I2 (enExample)
BE2011C004I2 (enExample)
BRPI0001672A2 (enExample)
BRPI0001542A2 (enExample)
BRPI0012675B8 (enExample)
BRPI0017522A2 (enExample)
BRPI0303609A (enExample)
BRMU7902607U2 (enExample)
BRPI9917761A2 (enExample)
CN3097510S (enExample)
CN3097853S (enExample)